Nasal spray peptides and sublingual peptides represent emerging delivery methods that may eventually apply to semaglutide or related compounds
These agents have been supported by important clinical trials, including Satiety and Clinical Adipose Liraglutide Evidence (SCALE), Semaglutide Treatment Effect in People with Obesity (STEP) program trials, and Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) (44)
Our providers create a treatment plan to best fit your needs and improve your symptoms
In my years of clinical practice, Ive identified five distinct types of obesityeach with different underlying causes: Caloric Obesity : Simply consuming more calories than your body burns Inflammatory Obesity : Where chronic inflammation triggers fat storage and prevents fat-burning Metabolic Obesity : Involving insulin resistance, hormonal imbalances, and a damaged metabolism Microbiome Obesity : When gut bacteria imbalances hijack your appetite and metabolism Chemical Obesity : Exposure to obesogensenvironmental chemicals that disrupt your bodys weight regulation Theres also a crucial neurological factor: When your nervous system stays in fight-or-flight mode, your body doesnt feel safe enough to release weight
Henmi H, Endo T, Kitajima Y, Manase K, Hata H, Kudo R